2. Внутренняя медицина, основанная на доказательствах 2018. Издание I. Перевод с польского. Под ред. П. Гаевски, А.И. Мартынов, В.А. Кокорин. Краков: Практическая медицина. 2018; 1680 с. ISBN: 978-83-7430-566-2.

3. Hawro T., Ohanyan T., Schoepke N. et al. The Urticaria Activity Score – Validity, reliability, and responsiveness. J Allergy Clin Immunol Pract. 2018; 6(4): 1185–90.e1. https://dx.doi.org/10.1016/j.jaip.2017.10.001.

4. Weller K., Groffik A., Church M.K. et al. Development and validation of the Urticaria Control Test: A patient-reported outcome instrument for assessing urticaria control. J Allergy Clin Immunol. 2014; 133(5): 1365–72, 1372.e1–6. https://dx.doi.org/10.1016/j.jaci.2013.12.1076.

5. Sharma M., Bennett C., Cohen S.N., Carter B. H1-antihistamines for chronic spontaneous urticaria. Cochrane Database Syst Rev. 2014; 2014(11): CD006137. https://dx.doi.org/10.1002/14651858. CD006137.

6. Kudryavtseva A.V., Neskorodova K.A., Staubach P. Urticaria in children and adolescents: An updated review of the pathogenesis and management. Pediatr Allergy Immunol. 2019; 30(1): 17–24. https://dx.doi.org/10.1111/pai.12967.

7. Государственный реестр лекарственных средств Минздрава России. Инструкции по медицинскому применению лекарственных препаратов с МНН дексаметазон в лекарственной форме таблетки. Доступ: https://grls.rosminzdrav.ru/GRLS.aspx?RegNumber=&MnnR=дексаметазон&lf=таблет&TradeNmR=&OwnerName=&MnfOrg=&MnfOrgCountry=&isfs=0&regtype=1%2c6&pag eSize=10&order=Registered&orderType=desc&pageNum=1 (дата обращения – 01.10.2023).

8. Long B.J., Koyfman A., Gottlieb M. Evaluation and management of angioedema in the emergency department. West J Emerg Med. 2019; 20(4): 587–600. https://dx.doi.org/10.5811/westjem.2019.5.42650.

9. Zuberbier T., Abdul Latiff A.H., Abuzakouk M. et al. The international EAACI/GA²LEN/ EuroGuiDerm/APAAACI guideline for the definition, classification, diagnosis, and management of urticaria. Allergy. 2022; 77(3): 734–66. https://dx.doi.org/10.1111/all.15090.

10. Экосистема PHARM PORTAL. Инструкции по применению лекарственных препаратов фармако-терапевтической группы «Противоаллергическое средство – H1-гистаминовых рецепторов блокатор». Доступ: https://grls.pharm-portal.ru/grls?filters%5Bptg%5D%5B0%5D%5Btext%5D=противоаллергическое%20средство%20-%20H1-гистаминовых%20рецепторов%20блокатор&pageSize=100 (дата обращения – 01.10.2023).

11. Государственный реестр лекарственных средств Минздрава России. Инструкции по медицинскому применению лекарственных препаратов с МНН бензгидрилпиперазинилбутилметилксантина сукцинат (теоритин). Доступ: http://grls.rosminzdrav.ru/ (дата обращения – 01.10.2023).

12. Church M.K., Tiongco-Recto M., Ridolo E. et al. A lifetime companion for the treatment of allergies. Curr Med Res Opin. 2020; 36(3): 445–54. https://dx.doi.org/10.1080/03007995.2019.1681134.

13. Staevska M., Popov T.A., Kralimarkova T. et al. The effectiveness of levocetirizine and desloratadine in up to 4 times conventional doses in difficult-to-treat urticaria. J Allergy Clin Immunol. 2010; 125(3): 676–82. https://dx.doi.org/10.1016/j.jaci.2009.11.047.

14. Siebenhaar F., Degener F., Zuberbier T. et al. High-dose desloratadine decreases wheal volume and improves cold provocation thresholds compared with standard-dose treatment in patients with acquired cold urticaria: A randomized, placebo-controlled, crossover study. J Allergy Clin Immunol. 2009; 123(3): 672–79. https://dx.doi.org/10.1016/j.jaci.2008.12.008. 15. Iriarte Sotes P., Armisen M., Usero- Barcena T. et al.; Urtigal, the Galician Group of Interest in Urticaria. Efficacy and safety of up-dosing antihistamines in chronic spontaneous urticaria: A systematic review of the literature. J Investig Allergol Clin Immunol. 2021; 31(4): 282–91. https://dx.doi.org/10.18176/jiaci.0649.

16. Kontou-Fili K., Maniatakou G., Demaka P. et al. Therapeutic effects of cetirizine in delayed pressure urticaria: Clinicopathologic findings. J Am Acad Dermatol. 1991; 24(6 Pt2): 1090–93. https://dx.doi.org/10.1016/0190-9622(91)70163-v.

17. Zuberbier T., Münzberger C., Haustein U. et al. Double-blind crossover study of high-dose cetirizine in cholinergic urticaria. Dermatology. 1996; 193(4): 324–27. https://dx.doi.org/10.1159/000246281.

18. Gimenez-Arnau A., Izquierdo I., Maurer M. The use of a responder analysis to identify clinically meaningful differences in chronic urticaria patients following placebocontrolled treatment with rupatadine 10 and 20 mg. J Eur Acad Dermatol Venereol. 2009; 23(9): 1088–91. https://dx.doi.org/10.1111/j.1468- 3083.2009.03289.x.

19. Guillen-Aguinaga S., Jauregui Presa I., Aguinaga- Ontoso E. et al. Updosing nonsedating antihistamines in patients with chronic spontaneous urticaria: A systematic review and meta- analysis. Br J Dermatol. 2016; 175(6): 1153–65. https://dx.doi.org/10.1111/bjd.14768.